Datasheet: Live Single Cell Functional Analysis with Beacon Discoveryâ„¢
Access Resource

Row rect Shape Decorative svg added to bottom

Accelerating Scientific
Momentum Year After Year

Since 2008, publications from Bruker Cellular Analysis have surged, highlighting global adoption of optofluidic and proteomic technologies and their role in transforming single-cell biology.

View all publications

TOTAL PUBLICATIONS

OPTOFLUIDICS
PROTEOMICS
Research Powered by Optofluidic
and Proteomic Technology

Explore these featured studies showcasing the most innovative and influential work powered by optofluidic and proteomic technologies from Bruker Cellular Analysis.

ANTIBODY DISCOVERY

Rapid isolation and profiling
of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein

Read more

CELL LINE DEVELOPMENT

Microfluidic chip-based
single-cell cloning to accelerate biologic
production timelines

Read more

T CELL PROFILING

Identification of antigen-specific functional CD8+ T cells using an optofluidic system independent of epitope information

Read more

PROTEOMICS

CAR T cells with dual
targeting of CD19 and CD22
in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial

Read more

Where Bruker Cellular Analysis Technologies
Are Making an Impact

From cancer biology to vaccines and infectious disease, Bruker Cellular Analysis supports impactful work across eleven scientific areas — a testament to the reach and versatility of our platforms.

Antibody Discovery

Cancer Immunology
Cell Line Development
Cellular & Regenerative Medicine
Immunology
Inflammation & Neurology
Oncology
Stem Cells
Synthetic Biology
T Cell Profiling
Vaccines & Infectious Disease

Scientific
Leadership By
the Numbers

Demonstrating scale and reach, these metrics highlight the role of Bruker Cellular Analysis in driving impactful, long-term research across the globe and scientific fields.

HIGH-IMPACT JOURNALS

43%

of publications appeared in journals with an impact factor greater than 10, underscoring the scientific significance and visibility of Bruker-enabled research.

CANCER CENTERS

90%

of comprehensive cancer centers incorporate optofluidic and proteomic technologies into their research pipelines, underscoring Bruker Cellular Analysis's role in supporting high-impact oncology and translational studies.

Search All Bruker Cellular
Analysis Publications

Learn More About Bruker Cellular Analysis Technologies